Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain
|ClinicalTrials.gov Identifier: NCT01058473|
Recruitment Status : Completed
First Posted : January 28, 2010
Last Update Posted : July 30, 2013
Historically, sickle cell disease has not been viewed in the chronic pain paradigm because of its recurrent nature. Patients with sickle cell disease may be hospitalized for extended periods of time. As the hospital stay progresses, patients with SCD pain are often observed by clinicians to have improvements in function in areas such as self-care, mobility, and recreation despite continued self-report of high pain scores. This pattern of functional improvement with continued report of high pain intensity scores is common in patients with recurrent and chronic pain. A functional assessment tool that can assess function in the acute inpatient setting is needed.
The purpose of this study is to evaluate the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ), as a measure of daily function in children with sickle cell disease hospitalized with vasoocclusive pain.
|Condition or disease|
|Sickle Cell Disease Pain|
|Study Type :||Observational|
|Actual Enrollment :||159 participants|
|Official Title:||Psychometric Evaluation of the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ) in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||December 2012|
|Sickle Cell Disease|
- IPPAQ [ Time Frame: 1 day ]This is a functional assessment tool for pediatric sickle cell patients that is admisistered once a day.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01058473
|United States, Connecticut|
|Connecticut Children's Medical Center|
|Hartford, Connecticut, United States, 06106|
|Principal Investigator:||William T. Zempsky, M.D.||Connecticut Children's Medical Center|